The influence of killed Propionibacterium granulosum on experimental infection with Escherichia coli

Insights

Propionibacterium granulosum pretreatment protected mice against lethal Escherichia coli infection, reducing bacterial liver counts. This immunotherapy enhanced resistance to bacterial systemic infection.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Systemic infections caused by Escherichia coli can be lethal.
  • The use of bacterial components as immunomodulators is an area of research.

Purpose of the Study:

  • To investigate the protective effect of killed Propionibacterium granulosum KP-45 against Escherichia coli infection in mice.

Main Methods:

  • Mice were infected subcutaneously with Escherichia coli ATCC 25922.
  • Mice were pretreated intraperitoneally with killed Propionibacterium granulosum KP-45.
  • Bacterial counts in the liver and spleen weight were assessed.

Main Results:

  • Escherichia coli infection led to systemic infection and death in mice within 6 days.
  • Pretreatment with Propionibacterium granulosum KP-45 increased spleen weight.
  • Pretreated mice showed significantly lower bacterial counts in the liver compared to controls, indicating protection.

Conclusions:

  • Killed Propionibacterium granulosum KP-45 confers protection against systemic Escherichia coli infection in mice.
  • This suggests a potential immunotherapeutic strategy for bacterial infections.